HDGF and hepatocellular carcinoma: And Shih et al. [34] found that decreased miR-214 level in human hepatocellular carcinoma (HCC) was associated with worse prognosis and contributed to de novo hypervascular HCC via induction of hepatoma-derived growth factor (HDGF) secretion [34].